TrialCancer research and treatment2019

Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.

Xueying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.